文献速递妇科

接受睾酮治疗的性别多元化人群阴道残端裂开风险增加

Increased vaginal cuff dehiscence among gender diverse people on testosterone.
PubMed 文献 · Am J Obstet Gynecol · 2025-03-27

本研究为回顾性队列研究,纳入2014年6月1日至2019年12月31日在整合医疗系统内因良性疾病行全子宫切除术的成人,比较接受睾酮治疗的性别多元化人群与顺性别女性的阴道残端裂开率。结果显示,性别多元化队列阴道残端裂开率为5.8%,顺性别女性为2.4%(P=.014),调整后比值比为2.18(95%CI 1.08-4.41,P=.030)。作者建议外科医生应意识到该人群阴道残端裂开风险增加,并在术后分诊时保持高度警惕。

要点

  • 接受睾酮治疗的性别多元化人群阴道残端裂开率为5.8%,顺性别女性为2.4%(P=.014)。
  • 性别多元化队列阴道残端裂开的调整OR为2.18(95%CI 1.08-4.41,P=.030)。
  • 年龄、高血压和手术时间均为阴道残端裂开的独立预测因素。

核心结论

  • 尽管合并症更少,接受睾酮治疗的性别多元化人群发生阴道残端裂开的风险是顺性别女性的两倍以上。
  • 外科医生应意识到接受睾酮治疗的性别多元化人群阴道残端裂开风险增加,并在术后分诊时保持高度警惕。
  • 需要进一步研究以更好地理解接受睾酮治疗的性别多元化人群阴道残端裂开的发病机制,并优化该人群子宫切除术的安全性。

研究设计与样本

  • 回顾性队列研究,纳入2014年6月1日至2019年12月31日在整合医疗系统内因良性疾病行全子宫切除术的成人。
  • 接受睾酮治疗的性别多元化人群需有至少6个月的术前睾酮使用史,所有患者随访至少6个月。
  • 共纳入21,200例患者,其中154例(0.7%)为接受睾酮治疗的性别多元化人群,21,046例(99.3%)为顺性别女性。
  • 主要结局基于国际疾病分类第九/十版临床修改版中阴道残端裂开的诊断代码。
  • 采用Kruskal-Wallis检验、卡方检验或Fisher精确检验进行比较,并采用多变量逻辑回归估计调整比值比。

主要发现

  • 性别多元化队列较顺性别队列更年轻(中位年龄27岁 vs 46岁,P<.001)。
  • 性别多元化队列合并症更少:Charlson合并症指数≥1者分别为18.2% vs 27.0%(P=.014);糖尿病分别为2.6% vs 6.8%(P=.039);高血压分别为11.0% vs 27.1%(P<.001)。
  • 性别多元化队列阴道残端裂开比例高于顺性别队列(5.8% vs 2.4%,P=.014)。
  • 性别多元化队列与阴道残端裂开的调整比值比为2.18(95%CI 1.08-4.41,P=.030)。
  • 子宫切除术时年龄(调整OR=0.95,95%CI 0.90-0.998,P=.043)、高血压(调整OR=1.38,95%CI 1.13-1.68,P=.002)和手术时间(调整OR=1.01,95%CI 1.003-1.02,P=.003)为阴道残端裂开的显著独立预测因素。

临床怎么用

  • 作者认为,外科医生应意识到接受睾酮治疗的性别多元化人群阴道残端裂开风险增加,并在术后分诊时保持高度警惕。

局限性

  • 需要进一步研究以更好地理解接受睾酮治疗的性别多元化人群阴道残端裂开的发病机制,并优化该人群子宫切除术的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A majority of gender diverse people undergoing gender-affirming hysterectomy have a history of gender-affirming testosterone use, so it is important for surgeons to understand the impact of preoperative testosterone on postoperative complications of hysterectomy. OBJECTIVE: To compare the rates of vaginal cuff dehiscence among gender diverse people on testosterone and cisgender women and to identify factors associated with vaginal cuff dehiscence. STUDY DESIGN: This is a retrospective cohort study of adults who underwent total hysterectomy from June 1, 2014, to December 31, 2019, for benign indications within an integrated healthcare delivery system. Gender diverse people on testosterone had at least 6 months of preoperative testosterone use, and all patients were followed for at least 6 months. The primary outcome was based on International Classification of Diseases, Ninth/Tenth Revision, Clinical Modification diagnosis codes for vaginal cuff dehiscence. Kruskal-Wallis, chi-squared, or Fisher exact tests were performed to compare gender diverse people on testosterone and cisgender women. Multivariable logistic regression was conducted to estimate adjusted odds ratio for vaginal cuff dehiscence. RESULTS: Of the 21,200 patients included, 154 (0.7%) were gender diverse people on testosterone and 21,046 (99.3%) were cisgender women. The gender diverse cohort was younger than the cisgender cohort (median age 27 vs 46 years, P<.001) and had fewer comorbidities (respectively, 18.2% vs 27.0% with a Charlson Comorbidity Index ≥1, P=.014; 2.6% vs 6.8% with diabetes mellitus, P=.039; and 11.0% vs 27.1% with hypertension, P<.001). A greater proportion of patients had vaginal cuff dehiscence in the gender diverse than cisgender cohort (5.8% vs 2.4%, P=.014). Being in the gender diverse cohort was associated with a 2.18 times higher adjusted odds of vaginal cuff dehiscence (95% confidence interval [CI], 1.08-4.41, P=.030). Age at hysterectomy (adjusted odds ratio=0.95 [95% CI, 0.90-0.998], P=.043), hypertension (adjusted odds ratio=1.38 [95% CI, 1.13-1.68], P=.002), and operative time (adjusted odds ratio=1.01 [95% CI, 1.003-1.02], P=.003) were significant, independent predictors of vaginal cuff dehiscence. CONCLUSION: Despite having fewer comorbidities, gender diverse people on testosterone had more than twice the risk of vaginal cuff dehiscence relative to cisgender women. Surgeons should be aware of the increased risk of vaginal cuff dehiscence among gender diverse people on testosterone and maintain a high index of suspicion when triaging postoperative complaints. Further investigation is needed to better understand the pathogenesis of vaginal cuff dehiscence among gender diverse people on testosterone and to optimize the safety of hysterectomy within this population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wong JWH, Xu RH, Vega S, et al. Increased vaginal cuff dehiscence among gender diverse people on testosterone. Am J Obstet Gynecol. 2025. PMID: 40157523. doi:10.1016/j.ajog.2025.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。